Percutaneous coronary interventions in elderly patients: Clinical indications and adjunctive medical treatment. The Italian Drug Evaluation in Angioplasty (IDEA) study;Procedure interventistiche coronariche percutanee in pazienti anziani: Indicazioni cliniche e terapie farmacologiche concomitanti. Lo studio Italian Drug Evaluation in Angioplasty (IDEA)

Giornale Italiano di Cardiologia

Volumn 7, Issue 2, 2006, Pages 136-144

  Bossi, Irene ^a   Piccaluga, Emanuela ^b   Scatturin, Melania ^c   Corvaja, Nicola ^d   Pasquetto, Giampaolo ^e   Steffanon, Luigi ^f   Oberhollenzer, Rainer ^g   Colombo, Paola ^a   Bolognese, Leonardo ^h   Savonitto, Stefano ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^e Ospedale Civile   (Italy)

^f HESPERIA HOSPITAL   (Italy)

^g OSPEDALE CA FONCELLO   (Italy)

^h IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Elderly; Glycoprotein IIb IIIa receptor antagonists; Interventional cardiology; Registries; Stents

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DICOUMAROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; TICLOPIDINE; TINOFEDRINE; TIROFIBAN; FIBRINOGEN RECEPTOR;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ELUTING STENT; ELDERLY CARE; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; STENT; STROKE; TREATMENT INDICATION; VASCULAR DISEASE; AGE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; FEMALE; HEART INFARCTION; ITALY; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STENTS; TREATMENT OUTCOME;

EID: 33645634221     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708-13.
2. Giugliano RP, Camargo CA Jr, Lloyd-Jones DM, et al. Elderly patients receive less aggressive medical and invasive management of unstable angina: potential impact of practice guidelines. Arch Intern Med 1998; 158: 1113-20.
3. De Servi S, Cavallini C, Dellavalle A, et al, for the ROSAI-2 Investigators. Non-ST-elevation acute coronary syndrome in the elderly: treatment strategies and 30-day outcome. Am Heart J 2004; 147: 830-6.
4. Savonitto S, Ambrosini V, Marzocchi A, et al, on behalf of the IDEA Survey Investigators and the Italian Society of Invasive Cardiology (GISE). Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study. Ital Heart J 2005; 6: 106-18.
5. Klein L, Block P, Brindis R, et al, for the ACC-NCDR Registry. Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol 2002; 40: 394-402.
6. Graham MM, Ghali WA, Faris PD, et al, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Survival after coronary revascularization in the elderly. Circulation 2002; 105:2378-84.
7. Weintraub WS, Veledar E, Thompson T, Burnette J, Jurkovitz C, Mahoney E. Percutaneous coronary intervention outcomes in octogenarians during the stent-era (National Cardiovascular Network). Am J Cardiol 2001; 88: 1407-10.
8. Hasdai D, Holmes DR Jr, Criger DA, Topol EJ, Califf RM, Harrington RA. Age and outcome after acute coronary syndromes without persistent ST-segment elevation. Am Heart J 2000; 139: 858-66.
9. Leoncini M, De Servi S, Badia T, Dabizzi RP. Sindromi coronariche acute senza sopraslivellamento del tratto ST: il problema del paziente anziano. Ital Heart J Suppl 2005; 6: 29-34.
10. TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet 2001; 358: 951-7.
11. Passamonti E, Pirelli S. Impatto decisionale delle patologie associate nella scelta tra strategia aggressiva e conservativa nei pazienti ottuagenari con sindrome coronarica acuta senza sopraslivellamento ST. Ital Heart J Suppl 2004; 5: 855-60.
12. Halon DA, Adawi S, Dobrecky-Mery I, Lewis BS. Importance of increasing age on the presentation and outcome of acute coronary syndromes in elderly patients. J Am Coll Cardiol 2004; 43: 346-52.
13. Ragosta M. Percutaneous coronary intervention in octogenarians and the safety of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 2003; 42: 433-6.
14. Bertrand ME, Simoons ML, Fox KA, et al, for the Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002; 23: 1809-40.
15. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with unstable angina). Circulation 2002; 106: 1893-900.
16. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47.
17. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 2004; 110: 588-636.
18. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998; 352: 87-92.
19. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-96.
20. The CAPTURE Investigators. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997; 349: 1429-35.
21. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/ IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339: 436-43.
22. Mak KH, Effron MB, Moliterno DJ. Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients. Drugs Aging 2000; 16: 179-87.
23. Bach RG, Cannon CP, Weintraub WS, et al. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004; 141: 186-95.
24. Di Chiara A, Chiarella F, Savonitto S, et al, on behalf of the BLITZ Investigators. Epidemiology of acute myocardial infarction in the Italian CCU network: the BLITZ study. Eur Heart J 2003; 24: 1616-29.
25. Montalescot G, Barragan P, Wittenberg O, et al, for the ADMIRAL Investigators. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-903.
26. Mehta RH, Granger CB, Alexander KP, Bossone E, White HD, Sketch MH Jr. Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks. J Am Coll Cardiol 2005; 45: 471-8.
27. Sadeghi HM, Grines CC, Chandra HR, et al. Percutaneous coronary interventions in octogenarians: glycoprotein IIb/IIIa receptor inhibitors' safety profile. J Am Coll Cardiol 2003; 42: 428-32.
28. Piper WD, Malenka DJ, Ryan TJ Jr, et al, for the Northern New England Cardiovascular Disease Study Group. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 2003; 145: 1022-9.
29. Di Chiara A, Fresco C, Savonitto S, et al, on behalf of the BLITZ-2 Investigators. Epidemiology of non-ST elevation acute coronary syndromes in the Italian cardiology network: the BLITZ-2 study. Eur Heart J 2006; 27: 393-405.
30. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.